Today is the first day of the 2015 Annual Meeting of the American Society of Clinical Oncology.
It's a time when all kinds of cancer researchers, cancer drug companies, and cancer healthcare professionals present papers and reports on their research and clinical trials, and already some releases are hitting the mainstream news.
There are other meetings throughout the year that have similar presentations--the results of the PALOMA-2 trial were released at last year's American Association of Cancer Research meeting, which resulted in early FDA approval of palbociclib/Ibrance, which resulted in me being able to take it now--but advance press on this one has been really promising.
And results on PALOMA-3 with news on whether Ibrance is helpful in Overall Survival (how long people live) in addition to Progression Free Survival (how long till the cancer evolves around it and grows again) are expected to be presented. Obviously I'm very interested in news about that one!
A lot of the research they will announce is still years away from being usable as cancer therapy, but it's progress and a sign that there are new things coming. And, hopefully, there will be something good coming to take the place once my cancer evolves around Ibrance. Maybe even something more permanant.
My brother sent me a link to one article based on brand new research with the subject: "Hold the line! Help is on the way!"
I love that! That's the plan, that's the goal, hold the line long enough for the next army to arrive.
And this weekend, we should get a first look at some of the armies making their way to my battlefield. And God willing, there will be at least a few butt-kicking regiments all geared up and getting ready jump on in and save the day.
No comments:
Post a Comment